Cardiogard embolic protection system for surgical valve reaplacement
Feature | Embolic Protection Devices

March 22, 2017 โ€” Two U.S. Food and Drug Administration (FDA)-cleared embolic protection systems designed to remove ...

Home March 22, 2017
Home
Technology | Left Atrial Appendage (LAA) Occluders

Aegis Medical Innovations Inc. announced that it has received Investigational Device Exemption approval from the U.S. Food and Drug Administration (FDA) to initiate a clinical trial in the U.S. for its Sierra Ligation System medical device. Aegis developed the Sierra technology in partnership with the Mayo Clinic in Rochester, Minn. Sierra could, with additional clinical research, prove to prevent stroke in patients with atrial fibrillation (AF), according to the company.

Home March 22, 2017
Home
ACC.17 late breaking trial presentations, ACC late-breakers,  American College of Cardiology late breaking studies
Feature | ACC

Here is a list of the American College of Cardiology (ACC) 2017 annual meeting late-breaking clinical trials presented ...

Home March 22, 2017
Home
Medtronic Corevalve Evolut Pro, TAVR system
Feature | Heart Valve Technology

March 22, 2017 โ€“ The U.S. Food and Drug Administration (FDA) and granted market clearance to the Medtronic CoreValve ...

Home March 22, 2017
Home
News | Computed Tomography (CT)

March 21, 2017 โ€” Toshiba Medical demonstrated its Forward projected model-based Iterative Reconstruction SoluTion (FIRST ...

Home March 21, 2017
Home
News | Advanced Visualization

March 21, 2017 โ€” EchoPixel recently announced progress in the clinical adoption of its True 3D virtual reality software ...

Home March 21, 2017
Home
Videos | Hemodynamic Support Devices

This video, provided by Abiomed, demonstrates the Impella percutaneous ventricular assist devices (pVAD). It offers ...

Home March 21, 2017
Home
RESOLVE study, RESOLVE trial, subclinical leaflet thrombosis
Feature | Heart Valve Technology

March 21, 2017 โ€” About 12 percent of patients undergoing aortic valve replacement developed non-symptomatic blood clots ...

Home March 21, 2017
Home
News | Cardiac Diagnostics

March 21, 2017 โ€” A blood test for a protein called high-sensitivity troponin T, which is released into the bloodstream ...

Home March 21, 2017
Home
BVS, Absorb stent, bioresorbable scaffold, ABSORB III data, ABSORB III results
Feature | Stents Bioresorbable | Dave Fornell

March 21, 2017 โ€” In the late-breaking ABSORB III Trial two year results presented at the American College of Cardiology ...

Home March 21, 2017
Home
Technology | Guidewires

March 20, 2017 โ€” Teleflex Inc. recently announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U ...

Home March 20, 2017
Home
Technology | Enterprise Imaging

March 20, 2017 โ€” Agfa HealthCare announced the release a new version of its Enterprise Imaging for Cardiology platform ...

Home March 20, 2017
Home
Technology | Cardiovascular Ultrasound

March 20, 2017 โ€” Cardiologists can now access the advanced ultrasound imaging technology needed for fast and confident ...

Home March 20, 2017
Home
iFR, iFR vs. FFR, ACC late breaking trial, iFR-SWEDEHEART, DEFINE-FLAIR, Justin E. Davies,
Feature | FFR Technologies

March 20, 2017 โ€” For patients experiencing angina (chest pain) or a heart attack, instantaneous wave-free ratio (iFR) ...

Home March 20, 2017
Home
Evolocumab, Repatha, LDL, ACC late breaker, best LDL lowering drug
Feature | Pharmaceuticals

March 20, 2017 โ€” The most important late-breaking pharmaceutical trial at the 2017 America College of Cardiology annual ...

Home March 20, 2017
Home
Subscribe Now